Stephanie Michaud
@SMichaudBCRx
Followers
169
Following
1K
Media
2
Statuses
495
President & CEO, BioCanRx
Ottawa, Ontario
Joined October 2017
Meet @CamilleLeahy , one of the brave individuals who have embarked on this experimental treatment alongside Dr. Michel Sadelain. Her story of courage and hope will inspire and move you, illustrating the profound impact of this therapy on real lives. https://t.co/iFofwm70u7
1
3
6
Had a great meeting last night with 13 advocates discussing ways to mobilize and participate in advocacy for cholangiocarcinoma! These meetings are co-hosted with Cholangio-Hepatocellularcarcinoma Canada + @curecc and happen every 2nd Wednesday of the month. See you July 10!
1
4
8
Join us at the Westin Harbour Castle in Toronto in April, 2025 to explore the latest progress in cancer immunotherapy. Stay tuned as we prepare to announce more details and registration information in the coming weeks and months! #summit4CI #immunotherapy #cancerresearch
0
7
21
Congratulations to the 24 recipients of funding through the Strategic Science Fund. For BioCanRx, the $38M over 5 years will allow us to continue to foster collaboration in cancer research & position Canada as a leader in the global fight to cure cancer. https://t.co/GWTK6IIU1y
0
3
11
Budget2024 is a big win for Canadian research. BioCanRx welcomes the announced new funding & key measures to boost research, innovation & productivity that will go a long way to driving Canadian discoveries from the bench to the bedside. https://t.co/k6R8lZ8JBQ
#CanadianResearch
0
4
11
A great start to the week with photos from Camille Leahy, patient advocate and CLIC1901 clinical trial participant representing Canada, BioCanRx, BCCA, TOH, OHRI at the 2024 Breakthrough Prize celebrating the 'Stars of Science' and Canadian Michel Sadelain. Félicitations!
0
2
6
Great to be working with you @NRC_CNRC on this important initiative!
#NRCHealth, together with the @BioCanRx Canadian-Led Immunotherapies in Cancer program, has developed a made-in-Canada CD22-CAR-T that could offer new treatment options for patients with blood cancers such as leukemia & lymphoma. https://t.co/kxfSYbz7hU
#NRCChallengeGeneTherapy
1
0
5
Congratulations to Dr. Rebecca Auer @auer_r on her new appointment at the @OttawaHospital! We are very proud to have Dr. Auer as a BioCanRx network investigator!
The Ottawa Hospital is delighted to announce the appointment of Dr. Rebecca Auer as Executive Vice-President of Research and Innovation at The Ottawa Hospital and CEO and Scientific Director of the hospital’s research institute. https://t.co/OeQmEQarUA
1
3
17
Thank you for sharing your brave stories Chris and Brenda. @c3_cholangio supports you and we urge the other provinces to join Quebec in giving patients access to pemigatinib. Please don’t deny these Canadian patients hope. #CCA #FGF2R
ctvnews.ca
A new dad from the Calgary area is pressing the province to fund a new cancer treatment that might improve his chances of seeing his daughter grow up.
1
11
26
All cholangiocarcinoma patients deserve hope….for those with an FGF2R translocation/fusion, pemigatinib provides that hope.
We've responded to @ArndtVogel and Dr. Jennifer Knox's call and sent a letter to Ontario Health Ministers and MPs from C3's co-founder @auer_r 📢 Our voice NEEDS to be heard! Lives depend on it. Join together for cholangiocarcinoma 💚🤝 @ONThealth
0
8
26
#BioCanRx wants to hear from you! We're asking the Canadian community engaging in, or looking to engage in, cancer #immunotherapy research to help us define our research program priorities. Please fill out our survey by Monday, April 8th: https://t.co/jeXCeTy1tD
#CancerResearch
0
7
10
On #WorldCancerDay, and every day, the #BioCanRx network is united in closing the gap in cancer care for everyone who is diagnosed with cancer! Read a message from Scientific Director Dr. John Bell and CEO & President Dr. @SMichaudBCRx: https://t.co/1OatGspfPm
#CloseTheCareGap
0
6
11
Are you an Indigenous undergrad student interested in a summer internship in #CancerResearch? #BioCanRx is hosting an informational webinar this Thurs. Jan. 25 at 1 pm ET. The summer internship offers hands-on experience & a $9,000 award. Details here: https://t.co/9HEf0fRdiM
0
2
1
Are you an Indigenous undergrad student interested in a summer internship in #CancerResearch? The internship offers hands-on experience & a $9,000 award. #BioCanRx is hosting an informational webinar on Thurs. Jan. 25 at 1 pm ET. Details here: https://t.co/9HEf0fRdiM
0
4
5
Informational webinar alert! Are you an Indigenous student interested in #CancerResearch? Learn about #BioCanRx’s Indigenous undergraduate summer internship program. The internship offers hands-on experience & a $9,000 award. Register to learn more: https://t.co/9HEf0fRdiM
0
2
2
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in phase 3 trial resulted in a significant improvement in overall survival. Learn more: https://t.co/DlCfOs7FW3 via @NLM_NIH
pubmed.ncbi.nlm.nih.gov
The Canadian Cancer Society and Merck & Co.
0
3
4
Merci au gouvernement fédéral d'avoir investi dans BioCanRx dans le cadre du Fonds scientifique stratégique. Cet investissement donne l'espoir aux patients qu'un jour nous pourrons transformer tous les cancers en maladies curables. https://t.co/s2VZ8o96gK
0
1
5
An important announcement from the Government of Canada that will enable the delivery of life-saving clinical trials to cancer patients using made-in-Canada immunotherapies from @BioCanRX. TSA is very proud to support BioCanRX’s work on turning all cancers into curable diseases.
Thank you to the federal government for investing in BioCanRx under the Strategic Science Fund. This investment in Canadian #immunotherapies provides hope for patients that one day we can turn all cancers into curable diseases. Learn more about the SSF: https://t.co/sMECypd3rr
1
3
11
Thank you for your support throughout, Don!
Great to see new Government funding for cutting edge cancer research here in Canada.
0
0
1